2024 IOTOX Symposium: Treating Immune-Related Adverse Events – Integrating Insights from Clinical, Translational and Basic Science

The IOTOX Symposium is designed to bring a diverse range of stakeholders together to foster collaboration, share cutting-edge research findings, and discuss treatment advancements in the field of immunotherapy toxicities. The Symposium will provide a platform for attendees to engage in in-depth discussions and attend presentations that highlight new methodologies, emerging technologies, and innovative clinical management strategies. By facilitating network and knowledge exchange, the Symposium seeks to drive scientific progress and translate research into practical treatment options to improve patient outcomes.

Call for Abstracts
We invite faculty, trainees and staff to submit abstracts in the areas of clinical, translational, and basic science research.

Submission deadline has been extended. To be considered for oral presentation, submit by Sunday, Sept. 29, 11:59pm.

Submissions received between Sept 30 and Nov 1 will be for poster presentation only.

Click here to submit

1. Construct the guideline recommendations for each toxicity.
2. Identify location and use of national societies guidelines for IOTOX.
3. Implement IOTOX guidelines that are vetted by both oncologists and internal medicine specialists.
4. Identify patient treatment plans to evaluate difficult patient circumstances as it pertains to IOTOX.
5. Employ treatment plans and IOTOX guidelines to all providers including Pharmacists, APPs, Nurses and Trainees.

A Hybrid Live Streaming Course

The 2024 IOTOX Symposium will begin at 1:00 PM on Wednesday, November 6, 2024 and will adjourn at 4:00 PM on Thursday, November 7, 2024. (NOTE: All time is Central Standard Time (CST). 

 Location: TMC3 Collaborative Building - 7255 Helix Park Avenue, Floor 1, Main Atrium of TMC3, Houston, TX 77030. GPS Location: 1885 Old Spanish Trail, Houston, TX 77030

Parking: TMC3 Garage, located on Dynamic Way.

When registering, you must choose to attend in person or to attend via Zoom

REGISTRATION FEES

Telephone registrations are not accepted.

We accept the following forms of payment:
Credit Cards (MasterCard, VISA, and American Express)
Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
P.O. Box 301407
Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form. 

Refund/Cancellation Policy
The registration fee, minus a $25 administration-handling fee, is refundable if a written request is received on or before October 6, 2024 for both activities. No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Special Assistance or Additional Information
Contact Continuing Professional Education / Activity Management at 713-792-2223 or 866-849-5866. You may also email CPE at [email protected].  

Ground Transportation:
Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU).  The following ground transportations are available to and from the airports to the Medical Center.
     • Uber and Lyft
     • Taxicabs: Yellow Cab 713-236-1111; Fiesta Cab 713-225-2666.
     • Super Shuttle: For more information, call toll free at 800-258-3826, or on-line at www.supershuttle.com.

Evaluation:
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the review course.

Come for IOTOX, stay for SITC!

Society for Immunotherapy of Cancer’s 39^th Annual Meeting and Pre-Conference Programs (SITC)

November 8–10, 2024 | Houston, Texas | George R. Brown Convention Center 

SITC 2024 is the largest conference focused solely on cancer immunotherapy, providing international leaders from academia, regulatory and government agencies, and industry representatives, with a multidisciplinary environment focused on improving outcomes for all cancer patients.

Register here

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 9.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this live activity will award 9.00 Nursing Contact Hour(s).

The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

AMERICAN BOARD OF INTERNAL MEDICINE (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.  In order to receive MOC points, you must pass the post-test with a score of 70% or higher. 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

Hyatt House Houston Medical Center
7329 Fannin Street, Houston, Texas, 77030
(346) 502-4704
Shuttle: 6:30AM- 8PM up to 2 mile radius

DoubleTree by Hilton Houston Medical Center Hotel & Suites
6800 Main St, Houston
(713) 528-7744
Shuttle: 6AM- 7PM up to 3 mile radius

Hilton Houston Plaza/Medical Center
6633 Travis St, Houston
(713) 313-4000
Shuttle: 6:30AM- 8PM up to 2 mile radius

https://www.tmc.edu/contact/lodging/

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Roza Nurieva, PhD
Professor
The University of Texas MD Anderson. Cancer Center

Activity Co-Director, Faculty, Other Planning Committee Member

Nothing to disclose

Adi Diab, MD
Associate Professor
MD Anderson Cancer Center

Co-Director, Faculty

Consulting Fee-Lytix Biopharma|Consulting Fee-Nektar Therpaeutics|Consulting Fee-Idera Pharmaceuticals|Consulting Fee-Apexigen

Kristen Pauken, PhD
Assistant Professor
MD Anderson Cancer Center

Co-Director, Faculty

Consulting Fee-Guardant Health

Bilal A Siddiqui, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Co-Director, Faculty

Nothing to disclose

Ashley Aaroe, MD
MD Anderson Cancer Center

Faculty

Nothing to disclose

Ala Abudayyeh, MD
Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Michael Dougan, MD, PhD
Dr.
Harvard Medical School, Massachusetts General Hospital

Faculty

Advisor-Genentech, Inc.|Advisor-Mallinckrodt Pharmaceuticals|Advisor-Monod Bio|Advisor-Axxis Bio|Advisor-Cerberus Therapeutics|Advisor-Genentech, Inc. (Relationship has ended)|Advisor-Generate Biomedicines|Consulting Fee-Aditum|Consulting Fee-Foghorn Therapeutics|Consulting Fee-Sorriso Pharmaceuticals|Consulting Fee-Third Rock Ventures|Consulting Fee-Astellas Scientific and Medical Affairs, Inc.|Consulting Fee-Asher Bio|Consulting Fee-DE Shaw Research|Consulting Fee-Alloy Therapeutics|Consulting Fee-Agenus

Christopher R. Flowers, MD, FASCO
Chair, Lymphoma/Myeloma, Division Head Ad Interim, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center

Faculty

Consulting Fee-Beigene|Consulting Fee-BioAscend (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Curio Sciences (Relationship has ended)|Consulting Fee-Denovo Biopharma |Consulting Fee-Epizyme, Inc.|Consulting Fee-Genentech, Inc.|Consulting Fee-Foresight Diagnostics|Ownership-Foresight Diagnostics|Stocks or stock options, excluding diversified mutual funds-Foresight Diagnostics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Foresight Diagnostics|Consulting Fee-Genmab (Relationship has ended)|Consulting Fee-MorphoSys AG |Consulting Fee-Janssen Biotech, Inc. (Relationship has ended)|Consulting Fee-Seattle Genetics, Inc. (Relationship has ended)

Pauline Funchain, MD
Cleveland Clinic

Faculty

Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Eisai, Inc.|Advisor-GigaGen|Consulting Fee-Replimune|Consulting Fee-Immunocore|Consulting Fee-Sanofi US|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Grant or research support-Taiho Oncology, Inc. (Relationship has ended)|Grant or research support-Pfizer Inc. (Relationship has ended)|Grant or research support-Ideaya

Matthew J Hadfield, DO
Brown University/Legorreta Cancer Center

Faculty

Nothing to disclose

Noah I Hornick, MD, PhD, FAAD
Oregon Health & Science University

Faculty

Paid consultant-Sanofi US (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Mallinckrodt Pharmaceuticals

Nupur Kikani, MD
MD Anderson Cancer Center

Faculty

Nothing to disclose

Alexa Meara, MD
Associate Professor
The Ohio State University

Faculty

Consulting Fee-AbbVie Inc.|Consulting Fee-Sanofi US|Consulting Fee-Amgen Inc.|Consulting Fee-AstraZeneca US

Bianca Santomasso, MD, PhD
Assistant Attending
Memorial Sloan Kettering Cancer Center

Faculty

Consulting Fee-Bristol-Myers Squibb Company (Relationship has ended)|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-Gilead Sciences, Inc. (Relationship has ended)

Padmanee Sharma, MD, PhD
Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Felipe Soto Lanza, MBBS,MD
Postdoctoral Fellow
MD Anderson Cancer Center
Mexico

Faculty

Nothing to disclose

Naimah Turner, MS
Research Assistant II
MD Anderson Cancer Center

Faculty

Nothing to disclose

David J. Tweardy, MD
Division Head
MD Anderson Cancer Center

Faculty

Advisor-Tvardi Therapeutics, Inc.

Noha Abdelwahab Hassan, MD, PhD
Assistant Professor
University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Synat Keam Sr., PhD
Dr
UT MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Seyed Javad M. Moghaddam, MD
Associate Professor
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Grant or research support-Boehringer Ingelheim (Relationship has ended)

Nicolas Palaskas, MD
Assistant Professor
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Consulting Fee-Kiniksa Pharmaceuticals|Honoraria-Scripps (Relationship has ended)|Honoraria-Society of Immunotherapy for Cancer (Relationship has ended)|Consulting Fee-Replimmune|Honoraria-Patient Education Resource (Relationship has ended)

Ajay Sheshadri, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Enanta Pharmaceuticals (Relationship has ended)|Consulting Fee-ADC Therapeutics (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi US (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Seattle Genetics, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lyell Immunopharma

Sumit K Subudhi, MD, PhD
Associate Professor
UT MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Yinghong Wang, MD, PhD
Professor, Gastroenterology Hepation & Nutrition
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Consulting Fee-Sorriso Pharma|Consulting Fee-MabQuest (Relationship has ended)|Consulting Fee-AzurRx (Relationship has ended)|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-IOTA|Consulting Fee-Biontech|Consulting Fee-Kanvas Bio|Consulting Fee-ilyapharma|Consulting Fee-Mallinckrodt Pharma

Sebastian T Wurster, MD
Assistant Professor
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Grant or research support-Gilead Sciences, Inc. (Relationship has ended)|Grant or research support-Astellas Scientific and Medical Affairs, Inc.

Marian Taylor, DNP, RN, CMSRN
Continuing Education Specialist
MD Anderson Cancer Center

Nurse Planner

Nothing to disclose

Zita Lim, PA-C, PA-C
Physician Assistant
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Honoraria-Exelixis

Amy Spelman, PhD
Director, Research Planning and Development
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Mianen Sun, PhD
Director, Research Planning and Development
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Tricia White-Rhemtulla, MBA
Director of Administration
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Disclaimer: By clicking on "Exhibitors" you have left the accredited educational content of the course.

Bronze Level

Merck

Exhibitor Level

Astellas

Bristol Myers Squibb

Ferring

La Roche Posay

Regeneron

Sanofi